查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601307

自行注射药物市场：按类型、应用、通路、治疗领域应用分类 - 全球预测 2025-2030

Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

据预测，2023年自行注射药品市值为540亿美元，预计到2024年将达到606.4亿美元，复合年增长率为12.72%，到2030年将达到1248.7亿美元。

自行注射药物市场包括允许患者在没有专业帮助的情况下皮下注射药物的设备和技术。该市场的驱动因素包括慢性病的增加、对家庭医疗保健的日益重视以及对具有成本效益的治疗的需求。自行注射药物对于治疗糖尿病、类风湿性关节炎和多发性硬化症等疾病是必要的，可以为患者提供自主权，并与门诊病人治疗的转变保持一致。促进市场成长的关键因素包括全球老年人口的增加、生技药品的进步以及注射设备易用性的提高。开发整合数位健康平台以进行即时监测和依从性的智慧自行注射系统，以及为慢性病发病率迅速上升的新兴市场开发产品，都存在机会。然而，先进自行注射系统的高成本、欠发达地区缺乏认识以及患者对针头的恐惧等挑战可能会抑制采用率。此外，监管障碍和不平衡的报销政策也构成了重大障碍。公司可以透过投资以患者为中心的创新来推动成长，这些创新打破传统界限并满足特定患者的需求，例如无针注射器和用户友好的应用程式辅助设备。无痛分娩技术的探索和针对首次患者的密集训练模组可能会改变市场格局。与促进教育倡议的医疗保健提供者合作也可以提高患者的信任和依从性。该市场充满活力但分散，其特点是存在多个追求技术优势的主要企业。专注于永续的製造流程和强大的上市后监督系统对于公司应对不断变化的环境政策和政策至关重要。总体而言，自行注射市场是一个充满前景的市场，有望实现创新主导成长，特别是透过策略联盟和技术进步来满足日益健康意识增强的全球人口的需求。

主要市场统计
基准年[2023] 540亿美元
预测年份 [2024] 606.4亿美元
预测年份 [2030] 1248.7亿美元
复合年增长率（%） 12.72%

市场动态：揭示快速发展的自行注射药物市场的关键市场洞察

供需的动态交互作用正在改变自行注射药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病和类风湿性关节炎的快速流行
    • 自行注射药物在不孕症治疗的广泛应用
  • 市场限制因素
    • 产品召回的潜在风险
  • 市场机会
    • 世界各地政府继续核准自行注射药物
    • 自行注射装置的技术进步
  • 市场挑战
    • 对自行注射毒品的认知不足与管理挑战

波特五力：驾驭自行注射药物市场的策略工具

波特的五力框架是了解自行注射药物市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更具弹性的市场定位。

PESTLE分析：了解外部对自行注射药品市场的影响

外部宏观环境因素在塑造自行注射药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解自行注射药品市场竞争状况

对自行注射药物市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵自行注射药物市场供应商的绩效评估

FPNV 定位矩阵是评估自行注射药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性疾病和类风湿性关节炎的迅速传播
      • 用于不孕症治疗的自行注射药物的广泛使用
    • 抑制因素
      • 产品召回的潜在风险
    • 机会
      • 世界各地政府正在核准自行注射
      • 自动注射器的技术进步
    • 任务
      • 与自行注射药物相关的认识有限和管理挑战
  • 市场区隔分析
    • 类型：在慢性病管理中越来越偏好笔式註射器
    • 用途：一次性自行注射的使用越来越多，以避免交叉污染的风险
    • 通路：自行注射毒品在网路平台的普及
    • 治疗领域的应用：自行注射药物治疗荷尔蒙问题的应用正在扩大
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章自行注射药品市场：依类型

  • 自动注射器
  • 无针注射器
  • 笔式註射器
  • 穿戴式註射器

第七章自行注射药品市场应用

  • 一次性的
  • 可重复使用的

第八章自行注射药品市场：依通路

  • 医院药房
  • 网路药房
  • 私人诊所

第九章依治疗领域分類的自行注射药品市场应用

  • 自体免疫疾病
    • 爱滋病
    • 过敏
    • 癌症
    • 肠躁症
    • 多发性硬化症
    • 干癣
  • 急救药品
    • 过敏袜
    • 偏头痛
  • 荷尔蒙补充疗法
    • β干扰素
    • 促红血球生成素
    • 滤泡刺激素
    • 肝素
    • 胰岛素
    • 副甲状腺素
    • 帕金森氏症

第十章 美洲自行注射药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太自行注射药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲/中东/非洲自行注射药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 美光生物医学公司获得资金生产无针疫苗
    • Enable Injections 首次获得美国食品药物管理局(FDA)核准
    • Altaviz 推出新型药物输送自动注射器平台
    • FDA核准用于 PNH 治疗的自用内置注射器 pegcetacoplan
    • Civica 与 Ipsomed 合作开发胰岛素注射笔
    • Eitan Medical完成穿戴式註射器业务转型
    • Coherus 宣布在美国推出 UDENYCA 自动注射器
    • Ypsomed 透过综合人因服务增强自行注射设备平台
    • Viridian Therapeutics 宣布与药物传输创新者 Enable Injections 合作
    • 美国FDA核准Tezspire 使用预填充笔进行自我给药
    • Philips Medisize 推出笔式註射器平台，扩大产品系列，旨在降低药品成本、风险和市场壁垒

公司名单

  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • SCHOTT AG
  • Eli Lilly and Company
  • AstraZeneca plc
  • PharmaJet, Inc.
  • West Pharmaceutical Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Terumo Corporation
  • Enable Injections, Inc.
  • Owen Mumford Limited
  • SHL Medical AG
  • Merck KGaA
  • Sanofi SA
  • Recipharm AB
  • DALI Medical Devices Ltd.
  • Credence MedSystems, Inc.
  • Novo Nordisk A/S
  • Mylan NV by Viatris Inc.
  • GlaxoSmithKline plc
  • Gerresheimer AG
  • Medmix AG by Sulzer Ltd.
  • Molex LLC by Koch Industries, Inc.
  • PenJet Corporation
  • Ypsomed Group
  • Baxter International, Inc.
  • Pfizer Inc.
  • Becton, Dickinson and Company
  • Antares Pharma, Inc. by Halozyme, Inc.
  • AbbVie Inc.
Product Code: MRR-03050D1B2DB4

The Self-injections Market was valued at USD 54.00 billion in 2023, expected to reach USD 60.64 billion in 2024, and is projected to grow at a CAGR of 12.72%, to USD 124.87 billion by 2030.

The self-injections market encompasses devices and technologies that enable patients to administer medications subcutaneously without professional assistance. This market is driven by increased chronic disease prevalence, a growing emphasis on home healthcare, and the demand for cost-effective medical treatments. Self-injections are necessary for managing conditions such as diabetes, rheumatoid arthritis, and multiple sclerosis, providing patients with autonomy and aligning with the shift towards outpatient care. Key influencers of market growth include the rising global geriatric population, advances in biologics, and improved usability of injection devices. Opportunities exist in the development of smart self-injection systems that integrate digital health platforms for real-time monitoring and adherence, as well as expanding offerings for emerging markets where chronic diseases are rising rapidly. However, challenges such as high costs of advanced self-injection systems, lack of awareness in underdeveloped regions, and patients' needle anxiety may impede adoption rates. Additionally, regulatory hurdles and variability in reimbursement policies pose significant barriers. Companies can foster growth by investing in patient-centric innovations, such as needle-free injectors and user-friendly app-assisted devices, that break conventional boundaries and cater to specific patient needs. Research into pain-free delivery technologies and enhanced training modules for first-time users could revolutionize the market landscape. Partnerships with healthcare providers to promote educational initiatives can also improve patient confidence and compliance. The market is dynamic but fragmented, characterized by several key players striving for technological superiority. Enhanced focus on sustainable manufacturing processes and robust post-market surveillance systems will be vital as companies align themselves with evolving environmental policies and regulations. Overall, the self-injection market holds promising potential for innovation-led growth, particularly through strategic collaborations and technological advancements that cater to an increasingly health-conscious global population.

KEY MARKET STATISTICS
Base Year [2023] USD 54.00 billion
Estimated Year [2024] USD 60.64 billion
Forecast Year [2030] USD 124.87 billion
CAGR (%) 12.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Self-injections Market

The Self-injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid prevalence of chronic diseases and rheumatoid arthritis
    • Wide availability of self-injections for fertility treatments
  • Market Restraints
    • Potential risk of product recall
  • Market Opportunities
    • Ongoing government approvals for self-injections worldwide
    • Technological advancements in self-injection devices
  • Market Challenges
    • Limited awareness and administration challenges associated with self-injections

Porter's Five Forces: A Strategic Tool for Navigating the Self-injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Self-injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Self-injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Self-injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Self-injections Market

A detailed market share analysis in the Self-injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Self-injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Self-injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Self-injections Market, highlighting leading vendors and their innovative profiles. These include Insulet Corporation, Johnson & Johnson Services, Inc., SCHOTT AG, Eli Lilly and Company, AstraZeneca plc, PharmaJet, Inc., West Pharmaceutical Services, Inc., Teva Pharmaceutical Industries Ltd., Terumo Corporation, Enable Injections, Inc., Owen Mumford Limited, SHL Medical AG, Merck KGaA, Sanofi S.A., Recipharm AB, DALI Medical Devices Ltd., Credence MedSystems, Inc., Novo Nordisk A/S, Mylan N.V. by Viatris Inc., GlaxoSmithKline plc, Gerresheimer AG, Medmix AG by Sulzer Ltd., Molex LLC by Koch Industries, Inc., PenJet Corporation, Ypsomed Group, Baxter International, Inc., Pfizer Inc., Becton, Dickinson and Company, Antares Pharma, Inc. by Halozyme, Inc., and AbbVie Inc..

Market Segmentation & Coverage

This research report categorizes the Self-injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics.
  • Based on Therapeutic Areas Application, market is studied across Autoimmune Diseases, Emergency Drugs, and Hormone Replacement Therapies. The Autoimmune Diseases is further studied across AIDS, Allergies, Cancer, Irritable Bowel Disorders, Multiple Sclerosis, and Psoriasis. The Emergency Drugs is further studied across Anaphylactic Socks and Migraine. The Hormone Replacement Therapies is further studied across Beta-Interferon, Erythropoietin, Follicle Stimulating Hormone, Heparin, Insulin, Parathyroid Hormone, and Parkinson's.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
      • 5.1.1.2. Wide availability of self-injections for fertility treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing government approvals for self-injections worldwide
      • 5.1.3.2. Technological advancements in self-injection devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and administration challenges associated with self-injections
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
    • 5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
    • 5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
    • 5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Self-injections Market, by Type

  • 6.1. Introduction
  • 6.2. Auto-Injectors
  • 6.3. Needle-free Injectors
  • 6.4. Pen Injectors
  • 6.5. Wearable Injectors

7. Self-injections Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Self-injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Private Clinics

9. Self-injections Market, by Therapeutic Areas Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
    • 9.2.1. AIDS
    • 9.2.2. Allergies
    • 9.2.3. Cancer
    • 9.2.4. Irritable Bowel Disorders
    • 9.2.5. Multiple Sclerosis
    • 9.2.6. Psoriasis
  • 9.3. Emergency Drugs
    • 9.3.1. Anaphylactic Socks
    • 9.3.2. Migraine
  • 9.4. Hormone Replacement Therapies
    • 9.4.1. Beta-Interferon
    • 9.4.2. Erythropoietin
    • 9.4.3. Follicle Stimulating Hormone
    • 9.4.4. Heparin
    • 9.4.5. Insulin
    • 9.4.6. Parathyroid Hormone
    • 9.4.7. Parkinson's

10. Americas Self-injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Self-injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Self-injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
    • 13.3.2. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
    • 13.3.3. Altaviz introduces New Auto-Injector Platform For Drug Delivery
    • 13.3.4. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
    • 13.3.5. Civica Partners With Ypsomed For Insulin Injection Pen
    • 13.3.6. Eitan Medical Completes Transition of Wearable Injectors Business
    • 13.3.7. Coherus Announces U.S. Launch of UDENYCA Autoinjector
    • 13.3.8. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
    • 13.3.9. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
    • 13.3.10. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
    • 13.3.11. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers

Companies Mentioned

  • 1. Insulet Corporation
  • 2. Johnson & Johnson Services, Inc.
  • 3. SCHOTT AG
  • 4. Eli Lilly and Company
  • 5. AstraZeneca plc
  • 6. PharmaJet, Inc.
  • 7. West Pharmaceutical Services, Inc.
  • 8. Teva Pharmaceutical Industries Ltd.
  • 9. Terumo Corporation
  • 10. Enable Injections, Inc.
  • 11. Owen Mumford Limited
  • 12. SHL Medical AG
  • 13. Merck KGaA
  • 14. Sanofi S.A.
  • 15. Recipharm AB
  • 16. DALI Medical Devices Ltd.
  • 17. Credence MedSystems, Inc.
  • 18. Novo Nordisk A/S
  • 19. Mylan N.V. by Viatris Inc.
  • 20. GlaxoSmithKline plc
  • 21. Gerresheimer AG
  • 22. Medmix AG by Sulzer Ltd.
  • 23. Molex LLC by Koch Industries, Inc.
  • 24. PenJet Corporation
  • 25. Ypsomed Group
  • 26. Baxter International, Inc.
  • 27. Pfizer Inc.
  • 28. Becton, Dickinson and Company
  • 29. Antares Pharma, Inc. by Halozyme, Inc.
  • 30. AbbVie Inc.

LIST OF FIGURES

  • FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SELF-INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON'S, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 332. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 333. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023